UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Single Recurrent Mutation in the 5′-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V

American journal of human genetics, 2012-08, Vol.91 (2), p.343-348

2012

Volltextzugriff (PDF)

SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS

Journal of bone and mineral research, 2017-02, Vol.32 (2), p.397-406

2017

Volltextzugriff (PDF)

Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis

Arthritis research & therapy, 2017-07, Vol.19 (1), p.163-163, Article 163

2017

Volltextzugriff (PDF)

A CTGF‐RUNX2‐RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone

Journal of bone and mineral research, 2020-01, Vol.35 (1), p.155-166

2020

Volltextzugriff (PDF)

CXCL10 and autoimmune diseases

Autoimmunity reviews, 2009-03, Vol.8 (5), p.379-383

2009

Volltextzugriff (PDF)

Long-term comparative study of Substance-P with methylprednisolone on the development of osteoporosis

The Journal of Toxicological Sciences, 2014/06/01, Vol.39(3), pp.391-399

2014

Volltextzugriff (PDF)

N-acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells

Journal of cellular biochemistry, 2008-03, Vol.103 (4), p.1246-1255

2008

Volltextzugriff (PDF)

The interaction between CXCL10 and cytokines in chronic inflammatory arthritis

Autoimmunity reviews, 2013-03, Vol.12 (5), p.554-557

2013

Volltextzugriff (PDF)

The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-β–induced inhibitory signaling

Blood, 2008-01, Vol.111 (2), p.885-893

2008

Volltextzugriff (PDF)

Nrf2 is a novel regulator of bone acquisition

Bone (New York, N.Y.), 2014-06, Vol.63, p.36-46

2014

Volltextzugriff (PDF)

NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2

Nature communications, 2014-11, Vol.5 (1), p.5176-5176, Article 5176

2014

Volltextzugriff (PDF)

CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (13), p.3175-3186

2012

Volltextzugriff (PDF)

Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21

Experimental & molecular medicine, 2017-07, Vol.49 (7), p.e358-e358

2017

Volltextzugriff (PDF)

JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model

European journal of pharmacology, 2018-03, Vol.823, p.1-10

2018

Volltextzugriff (PDF)

Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts

Biochemical and biophysical research communications, 2003-05, Vol.305 (2), p.211-214

2003

Volltextzugriff (PDF)

Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation

Cell research, 2014-10, Vol.24 (10), p.1231-1249

2014

Volltextzugriff (PDF)

Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1

Experimental & molecular medicine, 2006-06, Vol.38 (3), p.256-264

2006

Volltextzugriff (PDF)

Nonsyndromic Multiple Mandibular Supernumerary Premolars

Journal of oral and maxillofacial surgery, 2008-07, Vol.66 (7), p.1366-1369

2008

Volltextzugriff (PDF)

Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival

The Journal of cell biology, 2012-12, Vol.199 (7), p.1145-1158

2012

Volltextzugriff (PDF)

Salt-inducible kinase 1 regulates bone anabolism via the CRTC1-CREB-Id1 axis

Cell death & disease, 2019-10, Vol.10 (11), p.826-15, Article 826

2019

Volltextzugriff (PDF)

NFI‐C Regulates Osteoblast Differentiation via Control of Osterix Expression

Stem cells (Dayton, Ohio), 2014-09, Vol.32 (9), p.2467-2479

2014

Volltextzugriff (PDF)

Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2

European journal of pharmacology, 2015-12, Vol.768, p.189-198

2015

Volltextzugriff (PDF)

Recessive Mutations in ACPT, Encoding Testicular Acid Phosphatase, Cause Hypoplastic Amelogenesis Imperfecta

American journal of human genetics, 2016-11, Vol.99 (5), p.1199-1205

2016

Volltextzugriff (PDF)

Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway

Scientific reports, 2017-09, Vol.7 (1), p.10626-16, Article 10626

2017

Volltextzugriff (PDF)

Reactive oxygen species mediate RANK signaling in osteoclasts

Experimental cell research, 2004-12, Vol.301 (2), p.119-127

2004

Volltextzugriff (PDF)

1 – 25 von 392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(363)

Publikationsform

Artikel
(391)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Single Recurrent Mutation in the 5′-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V

SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS

Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis

A CTGF‐RUNX2‐RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone

CXCL10 and autoimmune diseases

Long-term comparative study of Substance-P with methylprednisolone on the development of osteoporosis

N-acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells

The interaction between CXCL10 and cytokines in chronic inflammatory arthritis

The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-β–induced inhibitory signaling

Nrf2 is a novel regulator of bone acquisition

NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2

CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis

Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21

JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model

Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts

Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation

Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1

Nonsyndromic Multiple Mandibular Supernumerary Premolars

Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival

Salt-inducible kinase 1 regulates bone anabolism via the CRTC1-CREB-Id1 axis

NFI‐C Regulates Osteoblast Differentiation via Control of Osterix Expression

Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2

Recessive Mutations in ACPT, Encoding Testicular Acid Phosphatase, Cause Hypoplastic Amelogenesis Imperfecta

Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway

Reactive oxygen species mediate RANK signaling in osteoclasts

Suchergebnisse filtern